Cevimeline Hydrochloride Capsule
Product Images NDC 33342-216

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 33342-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cevimeline-container-30mg-100.jpg (Cevimeline Container 30mg 100)

Each capsule of this medication contains Cevimeline Hydrochloride 30 mg. The usual dosage information can be found in the prescribing information for Dosage and Administration. The capsules should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). This medication is manufactured by Macleods Pharma USA, Inc. in Princeton, NJ and Macleods Pharmaceuticals Ltd in Baddi, Himachal Pradesh, India.*

FDA Label Image

Cevimeline-structure.jpg (Cevimeline Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.